196 related articles for article (PubMed ID: 29243347)
21. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
Lutz MA; Lovato P; Cuesta G
Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
[TBL] [Abstract][Full Text] [Related]
22. Nicotine preloading for smoking cessation: the Preloading RCT.
Aveyard P; Lindson N; Tearne S; Adams R; Ahmed K; Alekna R; Banting M; Healy M; Khan S; Rai G; Wood C; Anderson EC; Ataya-Williams A; Attwood A; Easey K; Fluharty M; Freuler T; Hurse M; Khouja J; Lacey L; Munafò M; Lycett D; McEwen A; Coleman T; Dickinson A; Lewis S; Orton S; Perdue J; Randall C; Anderson R; Bisal N; Hajek P; Homsey C; McRobbie HJ; Myers-Smith K; Phillips A; Przulj D; Li J; Coyle D; Coyle K; Pokhrel S
Health Technol Assess; 2018 Aug; 22(41):1-84. PubMed ID: 30079863
[TBL] [Abstract][Full Text] [Related]
23. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.
Leaviss J; Sullivan W; Ren S; Everson-Hock E; Stevenson M; Stevens JW; Strong M; Cantrell A
Health Technol Assess; 2014 May; 18(33):1-120. PubMed ID: 24831822
[TBL] [Abstract][Full Text] [Related]
24. Modelling a budgetary impact analysis for funding drug-based smoking cessation therapies for patients with major depressive disorder in Spain.
Rejas-Gutiérrez J; Bruguera E; Cedillo S
Eur Psychiatry; 2017 Sep; 45():41-49. PubMed ID: 28728094
[TBL] [Abstract][Full Text] [Related]
25. A Cost-Effectiveness Analysis of Smoking-Cessation Interventions Prior to Posterolateral Lumbar Fusion.
Zhuang T; Ku S; Shapiro LM; Hu SS; Cabell A; Kamal RN
J Bone Joint Surg Am; 2020 Dec; 102(23):2032-2042. PubMed ID: 33038088
[TBL] [Abstract][Full Text] [Related]
26. A Cost-Effectiveness Analysis of Stop Smoking Interventions in Substance-Use Disorder Populations.
Healey A; Roberts S; Sevdalis N; Goulding L; Wilson S; Shaw K; Jolley C; Robson D
Nicotine Tob Res; 2019 Apr; 21(5):623-630. PubMed ID: 29733376
[TBL] [Abstract][Full Text] [Related]
27. Behavioural interventions for smoking cessation: an overview and network meta-analysis.
Hartmann-Boyce J; Livingstone-Banks J; Ordóñez-Mena JM; Fanshawe TR; Lindson N; Freeman SC; Sutton AJ; Theodoulou A; Aveyard P
Cochrane Database Syst Rev; 2021 Jan; 1():CD013229. PubMed ID: 33411338
[TBL] [Abstract][Full Text] [Related]
28. Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR): a pilot randomised control trial of the clinical effectiveness and cost-effectiveness of a bespoke smoking cessation service.
Peckham E; Man MS; Mitchell N; Li J; Becque T; Knowles S; Bradshaw T; Planner C; Parrott S; Michie S; Shepherd C; Gilbody S
Health Technol Assess; 2015 Mar; 19(25):1-148, v-vi. PubMed ID: 25827850
[TBL] [Abstract][Full Text] [Related]
29. Economic Impact of Financial Incentives and Mailing Nicotine Patches to Help Medicaid Smokers Quit Smoking: A Cost-Benefit Analysis.
Sung HY; Penko J; Cummins SE; Max W; Zhu SH; Bibbins-Domingo K; Kohatsu ND
Am J Prev Med; 2018 Dec; 55(6 Suppl 2):S148-S158. PubMed ID: 30454669
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.
Chen YF; Madan J; Welton N; Yahaya I; Aveyard P; Bauld L; Wang D; Fry-Smith A; Munafò MR
Health Technol Assess; 2012; 16(38):1-205, iii-v. PubMed ID: 23046909
[TBL] [Abstract][Full Text] [Related]
31. Cost-Effectiveness of Smoking Cessation Interventions in Patients With Ischemic Stroke and Transient Ischemic Attack.
Wechsler PM; Liberman AL; Restifo D; Abramson EL; Navi BB; Kamel H; Parikh NS
Stroke; 2023 Apr; 54(4):992-1000. PubMed ID: 36866670
[TBL] [Abstract][Full Text] [Related]
32. Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
Annemans L; Nackaerts K; Bartsch P; Prignot J; Marbaix S
Clin Drug Investig; 2009; 29(10):655-65. PubMed ID: 19715382
[TBL] [Abstract][Full Text] [Related]
33. [Cost-Effectiveness of Pharmacological Smoking Cessation Therapies - A Systematic Literature Review].
Aumann I; Rozanski K; Damm K; Graf von der Schulenburg JM
Gesundheitswesen; 2016 Oct; 78(10):660-671. PubMed ID: 27784123
[No Abstract] [Full Text] [Related]
34. The long-term cost-effectiveness of varenicline (12-week standard course and 12 + 12-week extended course) vs. other smoking cessation strategies in Canada.
von Wartburg M; Raymond V; Paradis PE
Int J Clin Pract; 2014 May; 68(5):639-46. PubMed ID: 24472120
[TBL] [Abstract][Full Text] [Related]
35. Financial incentives for quitting smoking in pregnancy: Are they cost-effective?
McMeekin N; Sinclair L; Robinson-Smith L; Mitchell A; Bauld L; Tappin DM; Boyd KA
Addiction; 2023 Aug; 118(8):1445-1456. PubMed ID: 36843417
[TBL] [Abstract][Full Text] [Related]
36. Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.
Cadier B; Durand-Zaleski I; Thomas D; Chevreul K
PLoS One; 2016; 11(2):e0148750. PubMed ID: 26909802
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of enhancing a Quit-and-Win smoking cessation program for college students.
Popp J; Nyman JA; Luo X; Bengtson J; Lust K; An L; Ahluwalia JS; Thomas JL
Eur J Health Econ; 2018 Dec; 19(9):1319-1333. PubMed ID: 29687268
[TBL] [Abstract][Full Text] [Related]
38. The SmokingPaST Framework: illustrating the impact of quit attempts, quit methods, and new smokers on smoking prevalence, years of life saved, medical costs saved, programming costs, cost effectiveness, and return on investment.
O'Donnell MP; Roizen MF
Am J Health Promot; 2011; 26(1):e11-23. PubMed ID: 21879928
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness analysis of clinical smoking cessation interventions in Thailand.
Tosanguan J; Chaiyakunapruk N
Addiction; 2016 Feb; 111(2):340-50. PubMed ID: 26360507
[TBL] [Abstract][Full Text] [Related]
40. Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan.
Igarashi A; Takuma H; Fukuda T; Tsutani K
Pharmacoeconomics; 2009; 27(3):247-61. PubMed ID: 19354344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
